查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012855

生物安全櫃市場：按等級、類型、最終用戶和應用分類－2026-2032年全球市場預測

Biological Safety Cabinet Market by Class, Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物安全櫃市場價值將達到 5.3287 億美元，到 2026 年將成長至 5.7468 億美元，到 2032 年將達到 9.6632 億美元，年複合成長率為 8.87%。

主要市場統計數據
基準年 2025 5.3287億美元
預計年份：2026年 5.7468億美元
預測年份 2032 9.6632億美元
複合年成長率 (%) 8.87%

簡明扼要、權威地介紹了當前生物安全櫃的優先事項，包括實驗室環境中的隔離、合規性和運作彈性。

生物安全櫃仍然是實驗室處理傳染性病原體、細胞培養和高靈敏度診斷檢測的基礎基礎設施。現代實驗室需要能夠提供穩定防護性能、保障使用者安全和潔淨工作環境的解決方案，同時也要簡化工作流程並確保符合法規要求。生物安全櫃技術的進步，包括改進的氣流管理、整合監控以及支援嚴格消毒的材料，正在改變實驗室對生命週期成本和營運風險的認知。

技術整合、更嚴格的法規和不斷發展的實驗室實踐如何重新定義生物安全櫃的性能預期和採購標準。

生物安全櫃產業正經歷一場變革，其驅動力包括技術創新、法規演進和實驗室操作規範的改變。新一代生物安全櫃整合了感測器網路，可即時監測氣流異常和過濾器性能，從而實現預測性維護並減少意外停機時間。這種向互聯設備的轉變與實驗室數位化進程相契合，使實驗室能夠將生物安全櫃遙測技術與環境監測平台和品管系統整合。

量化 2025 年美國關稅調整對生物安全設備採購、庫存策略和供應商關係的營運和採購外溢效應。

2025年美國關稅調整對採購生物安全櫃及相關組件的機構的籌資策略、供應鏈設計和供應商談判動態產生了實際的影響。部分進口商品關稅的提高推高了從受影響地區採購的生物安全櫃及其零件的總到岸成本，迫使採購團隊重新評估採購地點和合約條款。為此，許多採購方與供應商重新談判契約，爭取包含運費、延長保固期或捆綁式維護計劃等條款，以減輕成本影響。

詳細的細分分析揭示了類別、類型、最終用戶和應用程式之間的相互依賴性如何決定技術規格、採購偏好和支援需求。

詳細的細分分析揭示了不同等級、類型、最終用戶和應用場景的機櫃在規格、採購行為和支援需求方面存在顯著差異。基於等級，我們檢視了I級、II級和III級機櫃的整體情況，其中II級機櫃又細分為A1、A2、B1和B2。每個等級都有其獨特的密閉性、氣流和排氣要求，這些要求決定了安裝和認證要求。基於類型，機櫃分為水平和垂直兩種，這些類型的機櫃在人體工學、面積和工作流程適用性方面會影響使用者偏好和實驗室佈局決策。

影響美洲、歐洲、中東和非洲以及亞太地區採購行為和服務期望的區域趨勢和服務網路策略。

區域趨勢以不同的方式影響供應鏈、標準解讀和客戶期望。在美洲，終端使用者尤其重視服務應對力、與臨床工作流程的整合以及對聯邦和州安全法規的遵守，這推動了對本地服務網路和易於獲取的耗材的需求。在歐洲、中東和非洲，法規環境的多樣性和資源狀況的差異促使供應商提供廣泛的產品、靈活的資金籌措模式和全面的驗證文件，以支援不同的認證流程。

關鍵公司和競爭對手訊息，展示了服務模式、產品整合和生命週期支援如何推動生物安全解決方案的買家偏好和供應商差異化。

在生物安全櫃市場，競爭優勢越來越依賴卓越的服務、驗證支援和產品生命週期管理。領先的製造商和經銷商透過認證的現場服務網路、支援預測性維護計劃的數位化服務平台以及便於受監管客戶部署的綜合驗證方案包來脫穎而出。與過濾器製造商、感測器供應商和環境監控平台供應商建立策略夥伴關係，使供應商能夠提供整合解決方案而非單一設備，從而提高機構客戶的忠誠度。

為製造商和機構負責人提供切實可行的建議，以增強服務彈性、整合服務和提供培訓，同時降低整體擁有成本 (TCO) 和合規負擔。

行業領導企業可以透過優先考慮服務彈性、互通性和客戶教育來鞏固其市場領導地位。投資建造區域服務中心和培訓認證現場技術人員可以縮短平均維修時間，並在受法規環境中增強客戶信心。同樣重要的是開發開放式整合框架和應用程式介面 (API)，將機櫃遙測資料與實驗室資訊管理系統和集中式建築管理解決方案連接起來。這可以實現無縫資料流，並減輕品管團隊的管理負擔。

本報告概述了一種透明且穩健的調查方法，透過初步訪談、次要標準審查和三角驗證，對生物安全櫃的發展趨勢進行了基於證據的評估。

本調查方法結合了多方面的證據基礎和成熟的行業實踐，對產品功能、買家偏好和供應鏈響應進行了全面評估。主要資訊來源包括對實驗室管理人員、生物安全負責人、採購經理和現場服務技術人員的結構化訪談，以了解營運重點和決策標準。次要資訊來源則利用了同行評審的指導文件、國家和地區生物安全標準、製造商技術規範以及供應鏈信息，以確定產品性能和服務預期所處的背景。

結論總結了綜合技術服務網路和供應鏈韌性如何重塑生物安全櫃的採購和營運重點。

總而言之，生物安全櫃環境正朝著以服務為中心的一體化解決方案發展，以支援法規遵循、營運連續性和實驗室數位化。即時監控和模組化設計等技術進步為提高運作和更有效率的驗證創造了機會。同時，貿易和供應鏈趨勢也進一步凸顯了區域服務體系和彈性籌資策略的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物安全櫃市場：依類別分類

  • 一級
  • 二類
    • A1
    • A2
    • B1
    • B2
  • 三級

第9章：生物安全櫃市場：按類型分類

  • 水平的
  • 垂直的

第10章：生物安全櫃市場：依最終用戶分類

  • 學術和研究機構
  • 醫院/臨床檢查室
  • 工業研發
  • 製藥和生物技術

第11章：生物安全櫃市場：依應用領域分類

  • 細胞培養
  • 診斷
  • 微生物學
  • 藥物測試

第12章：生物安全櫃市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：生物安全櫃市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物安全櫃市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國生物安全櫃市場

第16章：中國生物安全櫃市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Air Science International, LLC
  • AirClean Systems, Inc.
  • AIRTECH Japan Ltd.
  • Berner International GmbH
  • Biolab Scientific Srl
  • CHC Biotech Co., Ltd.
  • Cruma SA
  • Donglian Har Instrument Co., Ltd.
  • Esco Micro Pte. Ltd.
  • EuroClone SpA
  • FASTER Srl
  • Germfree Laboratories, Inc.
  • Getinge AB
  • Heal Force Bio-Meditech Holdings Limited
  • Jinan Biobase Biotech Co., Ltd.
  • Labconco Corporation
  • LAMSYSTEMS CC
  • Mystaire Inc.
  • NuAire, Inc.
  • Shellab, Inc.
  • Suzhou Antai Airtech Co., Ltd.
  • Telstar, SL
  • The Baker Company, Inc.
  • Thermo Fisher Scientific Inc.
  • Yamato Scientific Co., Ltd.
Product Code: MRR-437D4595793A

The Biological Safety Cabinet Market was valued at USD 532.87 million in 2025 and is projected to grow to USD 574.68 million in 2026, with a CAGR of 8.87%, reaching USD 966.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 532.87 million
Estimated Year [2026] USD 574.68 million
Forecast Year [2032] USD 966.32 million
CAGR (%) 8.87%

A concise and authoritative introduction to current biological safety cabinet priorities spanning containment, compliance, and operational resilience across laboratory environments

Biological safety cabinets remain foundational infrastructure for laboratories performing work with infectious agents, cell culture, and sensitive diagnostic assays. Contemporary laboratories demand solutions that deliver consistent containment, user safety, and clean working conditions while enabling workflow efficiency and regulatory compliance. Advances in cabinet technology, such as improved airflow management, integrated monitoring, and materials designed for rigorous decontamination, are reshaping how facilities think about lifecycle costs and operational risk.

Stakeholders across academic research, clinical diagnostic operations, industrial research and development, and biopharmaceutical production are balancing competing priorities: the need to protect personnel and product integrity, the imperative to meet evolving regulatory and accreditation standards, and the pressure to optimize capital and operating expenditures. Decision makers are placing greater weight on equipment traceability, digital monitoring, and compatibility with laboratory information systems. Consequently, procurement strategies extend beyond purchase price to encompass serviceability, validation support, and long-term vendor partnerships, which is increasingly influencing procurement dialogues and vendor selection criteria.

How technological integration, regulatory tightening, and evolving laboratory practices are collectively redefining performance expectations and procurement criteria for biosafety cabinets

The landscape for biological safety cabinets is undergoing transformative shifts driven by technological innovation, regulatory evolution, and changing laboratory practices. New generations of cabinets incorporate sensor networks that provide real-time alerts for airflow deviations and filter performance, thereby enabling predictive maintenance and reducing unplanned downtime. This transition toward connected equipment is converging with laboratory digitization efforts, allowing facilities to integrate cabinet telemetry with environmental monitoring platforms and quality management systems.

Regulatory expectations and accreditation bodies are emphasizing standardized validation protocols and traceable records, prompting manufacturers to supply enhanced documentation and validation support. Additionally, workplace safety culture and heightened awareness of laboratory-acquired infections have elevated the priority of training and ergonomic design. As laboratories scale throughput and adopt more complex workflows, demand for configurable cabinet interiors and modular options has increased. These shifts collectively favor vendors that can demonstrate robust service networks, comprehensive training programs, and products designed for integration into modern laboratory ecosystems.

Quantifying the operational and procurement ripple effects of 2025 tariff adjustments in the United States on sourcing, inventory strategies, and supplier relationships for biosafety equipment

Tariff changes in the United States during 2025 introduced tangible implications for procurement strategies, supply chain design, and supplier negotiation dynamics for organizations acquiring biological safety cabinets and related components. Increased duties on specific imported goods amplified the total landed cost for units and spare parts sourced from affected regions, prompting procurement teams to revisit sourcing geographies and contractual terms. In response, a number of purchasers sought to renegotiate vendor agreements to include freight-in terms, extended warranty coverage, or bundled maintenance plans to mitigate the cost impact.

The tariff environment also accelerated conversations around regional sourcing and inventory buffering. Facilities with centralized procurement began exploring nearshoring alternatives or establishing multi-supplier strategies to maintain continuity of supply for critical consumables and replacement filters. At the same time, manufacturers responded by optimizing production footprints, qualifying alternate suppliers for critical components, and increasing transparency around origin labeling to help customers evaluate total cost implications. These adjustments illustrate how trade policy shifts can produce operationally focused responses across the value chain without changing the underlying regulatory and safety requirements that govern biosafety equipment.

Deep segmentation insights revealing how class, type, end user, and application interdependencies determine technical specifications procurement preferences and support needs

A granular view of segmentation reveals clear differentials in specification, procurement behavior, and support requirements across cabinet classes, types, end users, and applications. Based on Class, the landscape is studied across Class I, Class II, and Class III, with Class II further subdivided into A1, A2, B1, and B2, and each class imposes distinct containment, airflow, and exhaust requirements that shape installation and certification needs. Based on Type, cabinets are classified as Horizontal and Vertical designs, and the ergonomics, footprint, and workflow compatibility of these types influence user preference and laboratory layout decisions.

Based on End User, the customer base spans Academic & Research Institutes, Hospitals & Clinical Laboratories, Industrial R & D, and Pharmaceutical & Biotech, and each segment exhibits unique priorities: academic settings emphasize flexibility and cost-effective maintenance, clinical labs prioritize throughput and regulatory traceability, industrial R&D values modularity for diverse experimental workflows, and pharmaceutical and biotech customers demand stringent qualification packages and documented compliance support. Based on Application, common use-cases include Cell Culture, Diagnostics, Microbiology, and Pharmaceutical Testing, and the choice of cabinet is informed by contamination risk profiles, materials compatibility, and routine decontamination protocols. Understanding these intersecting segmentation dimensions enables product teams to align features, service offerings, and training packages to distinct buyer journeys while informing clinical engineers and facility planners on installation, validation, and long-term maintenance requirements.

Regional dynamics and service network strategies that influence procurement behavior and service expectations across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics shape supply chains, standards interpretation, and customer expectations in distinct ways. In the Americas, end users place heightened emphasis on service responsiveness, integration with clinical workflows, and alignment with federal and state safety regulations, which drives demand for local service networks and readily available consumables. In Europe, Middle East & Africa, a heterogeneous regulatory environment and a mix of resource settings have led suppliers to offer a wider spectrum of product configurations, flexible financing models, and comprehensive validation documentation to support diverse accreditation processes.

In Asia-Pacific, rapid expansion of research infrastructure, growing biopharma investment, and a rising number of clinical diagnostic facilities have increased focus on capacity expansion, local manufacturing partnerships, and scalable maintenance frameworks. Across all regions, localization of after-sales service and spare parts availability are primary determinants of buyer confidence; therefore, global suppliers are adapting by deploying regional service hubs, training local engineers, and tailoring documentation to regional regulatory expectations. These regional contrasts inform go-to-market strategies, pricing alignment, and service network investment decisions for manufacturers and distributors.

Key corporate and competitive intelligence demonstrating how service models product integration and lifecycle support drive buyer preference and vendor differentiation in biosafety solutions

Competitive positioning in the biosafety cabinet space increasingly hinges on service excellence, validation support, and product lifecycle management. Leading manufacturers and distributors differentiate through certified field service networks, digital service platforms that enable predictive maintenance scheduling, and comprehensive validation protocol packages that ease implementation for regulated customers. Strategic partnerships with filter manufacturers, sensor providers, and environmental monitoring platform vendors have enabled suppliers to offer integrated solutions rather than stand-alone equipment, thereby increasing stickiness with institutional customers.

Customer experience differentiators include rapid access to OEM replacement filters and parts, remote diagnostics capabilities, and structured training programs for laboratory personnel and biosafety officers. Service agreements that bundle periodic recertification, preventive maintenance, and on-site training are viewed favorably by organizations that must maintain continuous compliance and high uptime. Additionally, product roadmaps that incorporate modular upgrades, retrofit kits for legacy units, and compatibility with centralized monitoring systems help vendors maintain relevance across the installed base and support procurement strategies focused on long-term operational efficiency.

Actionable recommendations for manufacturers and institutional purchasers to strengthen service resilience integration and training while reducing total cost of ownership and compliance burden

Industry leaders can advance market leadership by prioritizing service resilience, interoperability, and customer education. Investing in regional service hubs and certified field technicians will reduce mean time to repair and enhance customer confidence in regulated environments. Equally important is the development of open integration frameworks and APIs that allow cabinet telemetry to connect with laboratory information management systems and centralized building management solutions, enabling seamless data flows and reducing administrative burden on quality teams.

Manufacturers should also expand training offerings that include virtual certification modules, on-site competency assessments, and documented qualification packages tailored to different end users. Strategic partnerships with local distributors and filter suppliers can mitigate tariff exposure and improve parts availability. Finally, adopting flexible commercial models-such as bundled service agreements, extended warranty packages, and retrofit options-will appeal to organizations seeking predictable operational budgets and simplified compliance pathways, thereby strengthening long-term vendor-customer relationships.

Transparent and robust research methodology outlining how primary interviews secondary standards review and triangulation produced an evidence-based assessment of biosafety cabinet dynamics

The research methodology combined a multi-source evidence base and validated industry practices to construct a comprehensive assessment of product capabilities, buyer preferences, and supply chain responses. Primary input included structured interviews with laboratory managers, biosafety officers, procurement leaders, and field service technicians to capture operational priorities and decision criteria. Secondary input comprised peer-reviewed guidance documents, national and regional biosafety standards, manufacturer technical specifications, and supply-chain intelligence to establish context for product performance and service expectations.

Data synthesis involved triangulating qualitative insights with documented certification protocols and vendor service offerings to identify consistent patterns in procurement behavior and technical requirements. The approach emphasized reproducibility of validation procedures, parity in comparative feature analysis, and careful attribution of regional regulatory influences. Where appropriate, sensitivity checks and cross-validation with field technicians and end users ensured that technical interpretations matched real-world operational constraints and maintenance practices.

Conclusion summarizing how integrated technology service networks and supply chain resilience are reshaping procurement and operational priorities for biosafety cabinets

In summary, the biological safety cabinet environment is evolving toward integrated, service-centric solutions that support regulatory compliance, operational continuity, and laboratory digitization. Technology enhancements such as real-time monitoring and modular design are creating opportunities for improved uptime and streamlined validation. Simultaneously, trade and supply chain dynamics have reinforced the importance of regional service capabilities and flexible sourcing strategies.

Decision makers should evaluate vendors not only on product specifications but also on documented validation support, spare parts logistics, and the ability to integrate cabinet telemetry into broader laboratory quality systems. Suppliers that combine rigorous technical performance with robust service ecosystems and clear documentation will be best positioned to meet the diverse needs of academic, clinical, industrial, and pharmaceutical users while navigating an increasingly complex procurement environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Safety Cabinet Market, by Class

  • 8.1. Class I
  • 8.2. Class II
    • 8.2.1. A1
    • 8.2.2. A2
    • 8.2.3. B1
    • 8.2.4. B2
  • 8.3. Class III

9. Biological Safety Cabinet Market, by Type

  • 9.1. Horizontal
  • 9.2. Vertical

10. Biological Safety Cabinet Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Hospitals & Clinical Laboratories
  • 10.3. Industrial R & D
  • 10.4. Pharmaceutical & Biotech

11. Biological Safety Cabinet Market, by Application

  • 11.1. Cell Culture
  • 11.2. Diagnostics
  • 11.3. Microbiology
  • 11.4. Pharmaceutical Testing

12. Biological Safety Cabinet Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biological Safety Cabinet Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biological Safety Cabinet Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Biological Safety Cabinet Market

16. China Biological Safety Cabinet Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Air Science International, LLC
  • 17.6. AirClean Systems, Inc.
  • 17.7. AIRTECH Japan Ltd.
  • 17.8. Berner International GmbH
  • 17.9. Biolab Scientific S.r.l.
  • 17.10. CHC Biotech Co., Ltd.
  • 17.11. Cruma S.A.
  • 17.12. Donglian Har Instrument Co., Ltd.
  • 17.13. Esco Micro Pte. Ltd.
  • 17.14. EuroClone S.p.A.
  • 17.15. FASTER S.r.l.
  • 17.16. Germfree Laboratories, Inc.
  • 17.17. Getinge AB
  • 17.18. Heal Force Bio-Meditech Holdings Limited
  • 17.19. Jinan Biobase Biotech Co., Ltd.
  • 17.20. Labconco Corporation
  • 17.21. LAMSYSTEMS CC
  • 17.22. Mystaire Inc.
  • 17.23. NuAire, Inc.
  • 17.24. Shellab, Inc.
  • 17.25. Suzhou Antai Airtech Co., Ltd.
  • 17.26. Telstar, S.L.
  • 17.27. The Baker Company, Inc.
  • 17.28. Thermo Fisher Scientific Inc.
  • 17.29. Yamato Scientific Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 116. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 117. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GCC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 134. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 135. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 140. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 141. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)